Domo (DOMO) 10-Q 9 Dec 22 2023 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Oct. 31, 2022	Dec. 01, 2022
Class of Stock [Line Items]
Document Type	10-Q
Document Period End Date	Oct. 31, 2022
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-38553
Entity Registrant Name	DOMO, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-3687433
Entity Address, Address Line One	772 East Utah Valley Drive
Entity Address, City or Town	American Fork
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84003
City Area Code	801
Local Phone Number	899-1000
Title of 12(b) Security	Class B Common Stock, par value $0.001 per share
Trading Symbol	DOMO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001505952
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A Common Stock
Class of Stock [Line Items]
Entity Common Stock, Shares Outstanding		3,263,659
Class B Common Stock
Class of Stock [Line Items]
Entity Common Stock, Shares Outstanding		31,281,307

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Current assets:
Cash, cash equivalents, and restricted cash	$ 71,082	$ 83,561
Accounts receivable, net of allowances of $3,793 and $2,166 as of January 31, 2022 and October 31, 2022, respectively	53,314	64,149
Contract acquisition costs, net	15,146	15,417
Prepaid expenses and other current assets	7,457	9,975
Total current assets	146,999	173,102
Property and equipment, net	19,834	17,584
Right-of-use assets	14,871	16,392
Contract acquisition costs, noncurrent, net	21,390	23,177
Intangible assets, net	2,814	2,875
Goodwill	9,478	9,478
Other assets	1,945	1,981
Total assets	217,331	244,589
Current liabilities:
Accounts payable	17,843	4,770
Accrued expenses and other current liabilities	45,928	59,976
Lease liabilities	4,062	3,439
Deferred revenue	157,915	168,335
Total current liabilities	225,748	236,520
Lease liabilities, noncurrent	15,239	16,757
Deferred revenue, noncurrent	3,100	2,420
Other liabilities, noncurrent	11,945	10,882
Long-term debt	107,424	103,988
Total liabilities	363,456	370,567
Commitments and contingencies
Stockholders' deficit:
Preferred stock, $0.001 par value per share; 10,000 shares authorized as of January 31, 2022 and October 31, 2022; no shares issued and outstanding as of January 31, 2022 and October 31, 2022	0	0
Additional paid-in capital	1,165,522	1,098,084
Accumulated other comprehensive income (loss)	(1,460)	388
Accumulated deficit	(1,310,221)	(1,224,483)
Total stockholders' deficit	(146,125)	(125,978)
Total liabilities and stockholders' deficit	217,331	244,589
Class A Common Stock
Stockholders' deficit:
Common stock	3	3
Class B Common Stock
Stockholders' deficit:
Common stock	$ 31	$ 30

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Allowance for doubtful accounts receivable	$ 2,166	$ 3,793
Preferred stock par value (in usd per share)	$ 0.001	$ 0.001
Preferred stock authorized (shares)	10,000,000	10,000,000
Preferred stock issued (shares)	0	0
Preferred stock outstanding (shares)	0	0
Class A Common Stock
Common stock par value (usd per share)	$ 0.001	$ 0.001
Common stock authorized (shares)	3,263,659	3,263,659
Common stock issued (shares)	3,263,659	3,263,659
Common stock outstanding (shares)	3,263,659	3,263,659
Class B Common Stock
Common stock par value (usd per share)	$ 0.001	$ 0.001
Common stock authorized (shares)	500,000,000	500,000,000
Common stock issued (shares)	31,281,307	29,729,822
Common stock outstanding (shares)	31,281,307	29,729,822

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Revenues [Abstract]
Total revenue	$ 79,026	$ 65,081	$ 229,021	$ 187,968
Cost of Revenue [Abstract]
Total cost of revenue	18,914	17,144	54,888	48,620
Gross profit	60,112	47,937	174,133	139,348
Operating Expenses [Abstract]
Sales and marketing	41,012	37,503	131,299	104,335
Research and development	24,583	21,984	73,108	57,511
General and administrative	13,029	13,430	42,514	36,032
Total operating expenses	78,624	72,917	246,921	197,878
Loss from operations	(18,512)	(24,980)	(72,788)	(58,530)
Other expense, net	(5,032)	(3,471)	(12,383)	(10,238)
Loss before income taxes	(23,544)	(28,451)	(85,171)	(68,768)
Provision for income taxes	167	62	567	89
Net loss	$ (23,711)	$ (28,513)	$ (85,738)	$ (68,857)
Net loss per share, basic (in usd per share)	$ (0.69)	$ (0.88)	$ (2.53)	$ (2.17)
Net loss per share, diluted (in usd per share)	$ (0.69)	$ (0.88)	$ (2.53)	$ (2.17)
Weighted-average number of shares used in computing net loss per share, basic (shares)	34,392	32,363	33,893	31,758
Weighted-average number of shares used in computing net loss per share, diluted (shares)	34,392	32,363	33,893	31,758
Subscription
Revenues [Abstract]
Total revenue	$ 69,041	$ 56,621	$ 201,022	$ 163,399
Cost of Revenue [Abstract]
Total cost of revenue	11,342	10,514	32,721	29,590
Professional services and other
Revenues [Abstract]
Total revenue	9,985	8,460	27,999	24,569
Cost of Revenue [Abstract]
Total cost of revenue	$ 7,572	$ 6,630	$ 22,167	$ 19,030

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (23,711)	$ (28,513)	$ (85,738)	$ (68,857)
Foreign currency translation adjustments	(759)	(80)	(1,848)	(230)
Comprehensive loss	$ (24,470)	$ (28,593)	$ (87,586)	$ (69,087)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Deficit - USD ($) $ in Thousands	Total	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class B Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Stockholders (deficit) equity, beginning balance (shares) at Jan. 31, 2021				3,263,659	27,271,435
Stockholders (deficit) equity, beginning balance at Jan. 31, 2021	$ (83,459)			$ 3	$ 27	$ 1,038,006	$ 877	$ (1,122,372)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]
Vesting of restricted stock units (shares)					703,571
Vesting of restricted stock units	1				$ 1
Shares repurchased for tax withholdings on vesting of restricted stock (shares)					(94,435)
Shares repurchased for tax withholdings on vesting of restricted stock	(6,244)					(6,244)
Issuance of common stock under employee stock purchase plan (shares)					505,020
Issuance of common stock under employee stock purchase plan	4,133					4,133
Exercise of stock options (shares)					31,188
Exercise of stock options	654					654
Stock-based compensation expense	10,074					10,074
Other comprehensive income (loss)	(4)						(4)
Net loss	(18,104)							(18,104)
Stockholders (deficit) equity, ending balance (shares) at Apr. 30, 2021				3,263,659	28,416,779
Stockholders (deficit) equity, ending balance at Apr. 30, 2021	(92,949)			$ 3	$ 28	1,046,623	873	(1,140,476)
Stockholders (deficit) equity, beginning balance (shares) at Jan. 31, 2021				3,263,659	27,271,435
Stockholders (deficit) equity, beginning balance at Jan. 31, 2021	(83,459)			$ 3	$ 27	1,038,006	877	(1,122,372)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]
Net loss	(68,857)	$ (7,077)	$ (61,780)
Stockholders (deficit) equity, ending balance (shares) at Oct. 31, 2021				3,263,659	29,345,776
Stockholders (deficit) equity, ending balance at Oct. 31, 2021	(112,557)			$ 3	$ 29	1,077,993	647	(1,191,229)
Stockholders (deficit) equity, beginning balance (shares) at Apr. 30, 2021				3,263,659	28,416,779
Stockholders (deficit) equity, beginning balance at Apr. 30, 2021	(92,949)			$ 3	$ 28	1,046,623	873	(1,140,476)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]
Vesting of restricted stock units (shares)					286,617
Vesting of restricted stock units	1				$ 1
Shares repurchased for tax withholdings on vesting of restricted stock (shares)					(16,612)
Shares repurchased for tax withholdings on vesting of restricted stock	(1,334)					(1,334)
Exercise of stock options (shares)					107,804
Exercise of stock options	2,509					2,509
Stock-based compensation expense	12,621					12,621
Exercise of common stock warrants (shares)					100,000
Other comprehensive income (loss)	(146)						(146)
Net loss	(22,240)							(22,240)
Stockholders (deficit) equity, ending balance (shares) at Jul. 31, 2021				3,263,659	28,894,588
Stockholders (deficit) equity, ending balance at Jul. 31, 2021	(101,538)			$ 3	$ 29	1,060,419	727	(1,162,716)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]
Vesting of restricted stock units (shares)					363,635
Vesting of restricted stock units	0				$ 0
Shares repurchased for tax withholdings on vesting of restricted stock (shares)					(16,613)
Shares repurchased for tax withholdings on vesting of restricted stock	(1,280)					(1,280)
Exercise of stock options (shares)					104,166
Exercise of stock options	745					745
Stock-based compensation expense	18,109					18,109
Other comprehensive income (loss)	(80)						(80)
Net loss	(28,513)	$ (2,876)	$ (25,637)					(28,513)
Stockholders (deficit) equity, ending balance (shares) at Oct. 31, 2021				3,263,659	29,345,776
Stockholders (deficit) equity, ending balance at Oct. 31, 2021	(112,557)			$ 3	$ 29	1,077,993	647	(1,191,229)
Stockholders (deficit) equity, beginning balance (shares) at Jan. 31, 2022		3,263,659	29,729,822	3,263,659	29,729,822
Stockholders (deficit) equity, beginning balance at Jan. 31, 2022	(125,978)			$ 3	$ 30	1,098,084	388	(1,224,483)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]
Vesting of restricted stock units (shares)					527,423
Issuance of common stock under employee stock purchase plan (shares)					164,959
Issuance of common stock under employee stock purchase plan	1,563					1,563
Exercise of stock options (shares)					37,727
Exercise of stock options	724					724
Stock-based compensation expense	25,328					25,328
Other comprehensive income (loss)	(703)						(703)
Net loss	(32,888)							(32,888)
Stockholders (deficit) equity, ending balance (shares) at Apr. 30, 2022				3,263,659	30,459,931
Stockholders (deficit) equity, ending balance at Apr. 30, 2022	(131,954)			$ 3	$ 30	1,125,699	(315)	(1,257,371)
Stockholders (deficit) equity, beginning balance (shares) at Jan. 31, 2022		3,263,659	29,729,822	3,263,659	29,729,822
Stockholders (deficit) equity, beginning balance at Jan. 31, 2022	$ (125,978)			$ 3	$ 30	1,098,084	388	(1,224,483)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]
Exercise of stock options (shares)	47,389
Net loss	$ (85,738)	$ (8,257)	$ (77,481)
Stockholders (deficit) equity, ending balance (shares) at Oct. 31, 2022		3,263,659	31,281,307	3,263,659	31,281,307
Stockholders (deficit) equity, ending balance at Oct. 31, 2022	(146,125)			$ 3	$ 31	1,165,522	(1,460)	(1,310,221)
Stockholders (deficit) equity, beginning balance (shares) at Apr. 30, 2022				3,263,659	30,459,931
Stockholders (deficit) equity, beginning balance at Apr. 30, 2022	(131,954)			$ 3	$ 30	1,125,699	(315)	(1,257,371)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]
Vesting of restricted stock units (shares)					533,234
Vesting of restricted stock units	1				$ 1
Exercise of stock options (shares)					4,605
Exercise of stock options	81					81
Stock-based compensation expense	20,451					20,451
Other comprehensive income (loss)	(386)						(386)
Net loss	(29,139)							(29,139)
Stockholders (deficit) equity, ending balance (shares) at Jul. 31, 2022				3,263,659	30,997,770
Stockholders (deficit) equity, ending balance at Jul. 31, 2022	(140,946)			$ 3	$ 31	1,146,231	(701)	(1,286,510)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]
Vesting of restricted stock units (shares)					278,480
Exercise of stock options (shares)					5,057
Exercise of stock options	56					56
Stock-based compensation expense	19,235					19,235
Other comprehensive income (loss)	(759)						(759)
Net loss	(23,711)	$ (2,250)	$ (21,461)					(23,711)
Stockholders (deficit) equity, ending balance (shares) at Oct. 31, 2022		3,263,659	31,281,307	3,263,659	31,281,307
Stockholders (deficit) equity, ending balance at Oct. 31, 2022	$ (146,125)			$ 3	$ 31	$ 1,165,522	$ (1,460)	$ (1,310,221)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Cash flows from operating activities
Net loss	$ (85,738)	$ (68,857)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	4,089	3,789
Non-cash lease expense	3,362	3,540
Amortization of contract acquisition costs	12,825	11,779
Stock-based compensation expense	64,864	40,851
Other, net	3,027	2,663
Change in operating assets and liabilities:
Accounts receivable, net	10,835	9,377
Contract acquisition costs	(11,687)	(11,719)
Prepaid expenses and other	2,063	4,949
Accounts payable	13,291	10,965
Operating lease liabilities	(3,378)	(2,380)
Accrued expenses and other liabilities	(11,872)	(5,972)
Deferred revenue	(9,740)	485
Net cash used in operating activities	(8,059)	(530)
Cash flows from investing activities
Purchases of property and equipment	(5,073)	(4,965)
Net cash used in investing activities	(5,073)	(4,965)
Cash flows from financing activities
Proceeds from shares issued in connection with employee stock purchase plan	1,563	4,133
Shares repurchased for tax withholdings on vesting of restricted stock	0	(8,858)
Proceeds from structured payables	6,624	0
Payments on structured payables	(6,624)	0
Proceeds from exercise of stock options	861	3,908
Net cash (used in) provided by financing activities	2,424	(817)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(1,771)	(237)
Net decrease in cash, cash equivalents, and restricted cash	(12,479)	(6,549)
Cash, cash equivalents, and restricted cash at beginning of period	83,561	90,794
Cash, cash equivalents, and restricted cash at end of period	71,082	84,245
Supplemental disclosures of cash flow information
Cash paid for income taxes, net of refunds	138	481
Cash paid for interest	6,266	5,111
Non-cash investing and financing activities
Operating lease right-of-use assets obtained for lease liabilities	2,203	17,588
Property and equipment acquired through tenant improvement allowance	653	139
Stock-based compensation capitalized as internal-use software	$ 1,089	$ 739

Overview and Basis of Presentat

Overview and Basis of Presentation	9 Months Ended
	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Overview and Basis of Presentation	Overview and Basis of Presentation Description of Business and Basis of Presentation Domo, Inc. (the Company) provides a cloud-based platform that digitally connects everyone from the CEO to the frontline employee with all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The Company is incorporated in Delaware. The Company's headquarters is located in American Fork, Utah and the Company has subsidiaries in the United Kingdom, Australia, Japan, Hong Kong, Singapore, New Zealand, Canada, and India. The accompanying unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year ends on January 31. Unaudited Condensed Consolidated Financial Statements The accompanying condensed consolidated balance sheet as of October 31, 2022, and the condensed consolidated statements of operations, comprehensive loss, and stockholders' deficit for the three and nine months ended October 31, 2021 and 2022, and the condensed consolidated statements of cash flows for the nine months ended October 31, 2021 and 2022 are unaudited. The unaudited condensed consolidated financial statements have been prepared on a basis consistent with the annual consolidated financial statements and, in the opinion of management, reflect all adjustments necessary to state fairly the Company's financial position as of October 31, 2022 and its results of operations for the three and nine months ended October 31, 2021 and 2022 and its cash flows for the nine months ended October 31, 2021 and 2022. The financial data and the other financial information disclosed in the notes to these condensed consolidated financial statements related to the three-month and nine-month periods are also unaudited. The results of operations for the three and nine months ended October 31, 2022 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2023 or for any other future year or interim period. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes thereto as of and for the year ended January 31, 2022, included in the Company's Annual Report on Form 10-K. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. The Company bases its estimates on historical experience and on other assumptions that its management believes are reasonable under the circumstances. Actual results could differ from those estimates. The Company’s estimates and judgments include the determination of standalone selling prices for the Company’s services, which are used to determine revenue recognition for arrangements with multiple performance obligations; the amortization period for deferred contract acquisition costs; valuation of the Company’s stock-based compensation and related service period; useful lives of fixed assets; capitalization and estimated useful life of internal-use software; the incremental borrowing rate used to calculate the present value of capitalized leases; valuation estimates used when evaluating impairment of long-lived and intangible assets including goodwill; and the allowance for doubtful accounts. Foreign Currency The functional currencies of the Company’s foreign subsidiaries are the respective local currencies. The cumulative effect of translation adjustments arising from the use of differing exchange rates from period to period is included in accumulated other comprehensive income within the condensed consolidated balance sheets. Changes in the cumulative foreign translation adjustment are reported in the condensed consolidated statements of stockholders’ deficit and the condensed consolidated statements of comprehensive loss. Transactions denominated in currencies other than the functional currency are remeasured at the end of the period and when the related receivable or payable is settled, which may result in transaction gains or losses. Foreign currency transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations. All assets and liabilities denominated in a foreign currency are translated into U.S. dollars at the exchange rate on the balance sheet date. Revenue and expenses are translated at the average exchange rate during the period, and equity balances are translated using historical exchange rates. Segment Information The Company operates as one operating segment. The Company’s chief operating decision maker is its chief executive officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance and allocating resources.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Cash, Cash Equivalents, and Restricted Cash Cash and cash equivalents may consist of cash on hand, money market funds and highly liquid investments purchased with an original maturity date of 90 days or less from the date of purchase. The fair value of cash equivalents approximated their carrying value as of January 31, 2022 and October 31, 2022. Restricted cash relates to an outstanding letter of credit established in conjunction with an amendment to an existing lease agreement. Accounts Receivable Accounts receivable are recorded at the invoiced amount (net of allowance), do not require collateral, and do not bear interest. The Company’s payment terms generally provide that customers pay within 30 days of the invoice date. The Company maintains an allowance for doubtful accounts and expected credit losses for amounts the Company does not expect to collect. In establishing the required allowance, management considers historical losses, current market conditions, customers’ financial condition and credit quality, the age of the receivables, and current payment patterns. Account balances are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Contract Acquisition Costs Contract acquisition costs, net are stated at cost net of accumulated amortization and primarily consist of deferred sales commissions, which are considered incremental and recoverable costs of obtaining a contract with a customer. Contract acquisition costs for initial contracts are deferred and then amortized on a straight-line basis over the period of benefit, which the Company has determined to be approximately four years. The period of benefit is determined by taking into consideration contractual terms, expected customer life, changes in the Company's technology and other factors. Contract acquisition costs for renewal contracts are not commensurate with contract acquisition costs for initial contracts and are recorded as expense when incurred if the period of benefit is one year or less. If the period of benefit is greater than one year, costs are deferred and then amortized on a straight-line basis over the period of benefit, which the Company has determined to be two years. Contract acquisition costs related to professional services and other performance obligations with a period of benefit of one year or less are recorded as expense when incurred. Amortization of contract acquisition costs is included in sales and marketing expenses in the accompanying condensed consolidated statements of operations. Amortization expense related to contract acquisition costs was $4.0 million and $4.2 million for the three months ended October 31, 2021 and 2022, respectively, and $11.8 million and $12.8 million for the nine months ended October 31, 2021 and 2022, respectively. There was no impairment charge in relation to contract acquisition costs for the periods presented. Property and Equipment, Net Property and equipment, net, are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets or over the related lease terms (if shorter). Repairs and maintenance costs are expensed as incurred. The estimated useful lives of property and equipment are as follows: Computer equipment and software 2-3 years Furniture, vehicles and office equipment 3 years Leasehold improvements Shorter of remaining lease term or estimated useful life Leases At the inception of a contract, the Company determines whether the contract is or contains a lease. Leases with a term greater than one year are recognized on the balance sheet as right-of-use (ROU) assets and lease liabilities. The Company has elected the short-term leases practical expedient which allows any leases with a term of 12 months or less to be considered short-term and thus not have an ROU asset or lease liability recognized on the balance sheet. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As these leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate incurred to borrow on a collateralized basis over a similar term and amount equal to the lease payments in a similar economic environment. The operating lease ROU asset also includes any lease payments made in advance of lease expense and excludes lease incentives and initial direct costs incurred. Certain lease terms include options to terminate or extend the lease for periods of one The Company has lease agreements with lease and non-lease components which the Company has elected to account for as a single lease component. On the lease commencement date, the Company establishes assets and liabilities for the present value of estimated future costs to retire long-lived assets at the termination or expiration of a lease. Such assets are depreciated over the lease term to operating expense. Income from subleases is recorded in other expense, net in the accompanying condensed consolidated statements of operations. Capitalized Internal-Use Software Costs The Company capitalizes certain costs related to development of its platform incurred during the application development stage. Costs related to preliminary project activities and post-implementation activities are expensed as incurred. Maintenance and training costs are also expensed as incurred. Capitalized costs are included in property and equipment. Capitalized internal-use software is amortized generally as subscription cost of revenue, with a smaller portion related to operations amortized as research and development within operating expenses. All capitalized internal-use software is amortized on a straight-line basis over its estimated useful life, which is generally three years. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. Goodwill and Intangible Assets Goodwill represents the excess of the purchase price in a business combination over the fair value of net tangible and intangible assets acquired. Goodwill and indefinite-lived intangible assets are not amortized, but rather tested for impairment at least annually on November 1 or more often if and when circumstances indicate that the carrying value may not be recoverable. Finite-lived intangible assets are amortized over their useful lives. Goodwill is tested for impairment based on reporting units. The Company periodically reevaluates the business and has determined that it continues to operate in one segment, which is also considered the sole reporting unit. Therefore, goodwill is tested for impairment at the consolidated level. The Company reviews its long-lived assets, including property and equipment, finite-lived intangible assets, and ROU assets for impairment whenever an event or change in facts and circumstances indicates that their carrying amounts may not be recoverable. Recoverability of these assets is measured by comparing the carrying amount to the estimated undiscounted future cash flows expected to be generated. If the carrying amount exceeds the undiscounted cash flows, the assets are determined to be impaired and an impairment charge is recognized as the amount by which the carrying amount exceeds fair value. There was no goodwill acquired and no impairment charges for goodwill or long-lived assets recorded during the periods presented. Revenue Recognition The Company derives revenue primarily from subscriptions to its cloud-based platform and professional services. Revenue is recognized when control of these services is transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those services, net of sales taxes. For sales through channel partners, the Company considers the channel partner to be the end customer for the purposes of revenue recognition as the Company's contractual relationships with channel partners do not depend on the sale of the Company's services to their customers and payment from the channel partner is not contingent on receiving payment from their customers. The Company's contractual relationships with channel partners do not allow returns, rebates, or price concessions. The price of subscriptions is generally fixed at contract inception and therefore, the Company's contracts do not contain a significant amount of variable consideration. Revenue recognition is determined through the following steps: • Identification of the contract, or contracts, with a customer • Identification of the performance obligations in the contract • Determination of the transaction price • Allocation of the transaction price to the performance obligations in the contract • Recognition of revenue when, or as, performance obligations are satisfied Subscription Revenue Subscription revenue primarily consists of fees paid by customers to access the Company’s cloud-based platform, including support services. The majority of the Company's subscription agreements have multi-year contractual terms and a smaller percentage have annual contractual terms. Revenue is recognized ratably over the related contractual term beginning on the date that the platform is made available to a customer. Access to the platform represents a series of distinct services as the Company continually provides access to and fulfills its obligation to the end customer over the subscription term. The series of distinct services represents a single performance obligation that is satisfied over time. The Company recognizes revenue ratably because the customer receives and consumes the benefits of the platform throughout the contract period. The Company's contracts are generally non-cancelable. Professional Services and Other Revenue Professional services revenue consists of implementation services sold with new subscriptions as well as professional services sold separately. Other revenue includes training and education. Professional services arrangements are billed in advance, and revenue from these arrangements is recognized as the services are provided, generally based on hours incurred. Training and education revenue is also recognized as the services are provided. Contracts with Multiple Performance Obligations Most of the Company's contracts with new customers contain multiple performance obligations, generally consisting of subscriptions and professional services. For these contracts, individual performance obligations are accounted for separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices are determined based on historical standalone selling prices, taking into consideration overall pricing objectives, market conditions and other factors, including contract value, customer demographics, platform tier, and the number and types of users within the contract. Deferred Revenue The Company's contracts are typically billed annually in advance. Deferred revenue includes amounts collected or billed in excess of revenue recognized. Deferred revenue is recognized as revenue as the related performance obligations are satisfied. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as a current liability and the remaining portion is recorded as a noncurrent liability. Cost of Revenue Cost of subscription revenue consists primarily of third-party hosting services and data center capacity; employee-related costs directly associated with cloud infrastructure and customer support personnel, including salaries, benefits, bonuses and stock-based compensation; amortization expense associated with capitalized software development costs; depreciation expense associated with computer equipment and software; certain fees paid to various third parties for the use of their technology and services; and allocated overhead. Allocated overhead includes items such as information technology infrastructure, rent, and employee benefit costs. Cost of professional services and other revenue consists primarily of employee-related costs associated with these services, including stock-based compensation; third-party consultant fees; and allocated overhead. Advertising Costs Advertising costs are expensed as incurred. Advertising expense was $2.4 million and $3.0 million for the three months ended October 31, 2021 and 2022, respectively, and $8.0 million and $10.7 million for the nine months ended October 31, 2021 and 2022, respectively. Research and Development Research and development expenses consist primarily of employee-related costs for the design and development of the Company's platform, contractor costs to supplement staff levels, third-party web services, consulting services, and allocated overhead. Research and development expenses, other than software development costs qualifying for capitalization, are expensed as incurred. Stock-Based Compensation The Company has granted stock-based awards, consisting of stock options and restricted stock units, to its employees, certain consultants and certain members of its board of directors. The Company records stock-based compensation based on the grant date fair value of the awards, which include stock options and restricted stock units, and recognizes the fair value of those awards as expense using the straight-line method over the requisite service period of the award. For restricted stock units that contain market conditions, the Company recognizes stock-based compensation based on the estimated grant date fair value of market condition awards using a Monte Carlo simulation, and the awards are expensed over the service period using an accelerated attribution method. Stock-based compensation expense related to purchase rights issued under the 2018 Employee Stock Purchase Plan (ESPP) is based on the Black-Scholes option-pricing model fair value of the estimated number of awards as of the beginning of the offering period. Stock-based compensation expense is recognized using the straight-line method over the offering period. Income Taxes The Company accounts for income taxes in accordance with the liability method of accounting for income taxes. Under this method, the Company recognizes a liability or asset for the deferred income tax consequences of all temporary differences between the tax basis of assets and liabilities and their reported amounts in the condensed consolidated financial statements that will result in taxable or deductible amounts in future years when the reported amounts of the assets and liabilities are recovered or settled. These deferred income tax assets or liabilities are measured using the enacted tax rates that will be in effect when the differences are expected to affect taxable income. Valuation allowances are provided when it is more-likely-than-not that some or all of the deferred income tax assets may not be realized. In assessing the need for a valuation allowance, the Company has considered its historical levels of income, expectations of future taxable income and ongoing tax planning strategies. Because of the uncertainty of the realization of its deferred tax assets, the Company has a full valuation allowance for domestic net deferred tax assets, including net operating loss carryforwards, and tax credits related primarily to research and development. Realization of its deferred tax assets is dependent primarily upon future U.S. taxable income. Tax positions are recognized in the condensed consolidated financial statements when it is more-likely-than-not the position will be sustained upon examination by the tax authorities. The Company’s policy for recording interest and penalties related to income taxes, including uncertain tax positions, is to record such items as a component of the provision for income taxes. Concentrations of Credit Risk and Significant Customers Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. Cash denominated in currencies other than the United States dollar represented 20% and 21% of total cash, cash equivalents, and restricted cash as of January 31, 2022 and October 31, 2022, respectively. The Company maintains its cash accounts with financial institutions where, at times, deposits exceed federal insured limits. The Company may invest its excess cash in money market funds, certificates of deposit, or in short-term investments consisting of highly-rated debt securities. No single customer accounted for more than 10% of revenue for the three and nine months ended October 31, 2021 and 2022. No single customer accounted for more than 10% of accounts receivable as of January 31, 2022 and one customer accounted for approximately 12% of accounts receivable as of October 31, 2022. The Company is primarily dependent upon third parties in order to meet the uptime and performance requirements of its customers. Any disruption of or interference with the Company's use of these third parties would impact operations. Net Loss per Share The Company computes net loss per share using the two-class method required for multiple classes of common stock and participating securities. The rights, including the liquidation and dividend rights, of the Class A common stock and Class B common stock are substantially identical, other than voting rights. Accordingly, the Class A common stock and Class B common stock share equally in the Company’s net losses. Basic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period increased by common shares that could be issued upon conversion or exercise of other outstanding securities to the extent those additional common shares would be dilutive. The dilutive effect of potentially dilutive securities is reflected in diluted net loss per share by application of the treasury stock method. During periods when the Company is in a net loss position, basic net loss per share is the same as diluted net loss per share as the effects of potentially dilutive securities are anti-dilutive. Recent Accounting Pronouncements In September 2022, the FASB issued ASU No. 2022-04, Liabilities - Supplier Finance Programs (Topic 450-50) : Disclosure of Supplier Finance Program Obligations , which requires entities that use supplier finance programs in connection with the purchase of goods and services to make certain annual disclosures about the the key terms of the programs and information about the obligations outstanding at the end of the reporting period, including a rollforward of those obligations. The guidance does not affect the recognition, measurement or financial statement presentation of supplier finance program obligations. The amendments in ASU 2022-04 are effective for all entities for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods within those fiscal years, except for the requirement to disclose rollforward information, which is effective prospectively for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company is currently evaluating the new guidance to determine the impact it may have on its consolidated financial statements and related disclosures.

Cash, Cash Equivalents, and Res

Cash, Cash Equivalents, and Restricted Cash	9 Months Ended
	Oct. 31, 2022
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash The amortized cost and estimated fair value of the Company’s cash, cash equivalents, and restricted cash as of January 31, 2022 and October 31, 2022 were as follows (in thousands): January 31, 2022 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value Cash $ 42,500 $ — $ — $ 42,500 Cash equivalents: Money market funds 25,878 — — 25,878 Certificates of deposit 15,183 — — 15,183 Total cash and cash equivalents $ 83,561 $ — $ — $ 83,561 October 31, 2022 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value Cash $ 43,544 $ — $ — $ 43,544 Cash equivalents: Money market funds 8,518 — — 8,518 Certificates of deposit 15,320 — — 15,320 Restricted cash (1) 3,700 — — 3,700 Total cash, cash equivalents, and restricted cash $ 71,082 $ — $ — $ 71,082 (1) Related to an outstanding letter of credit. See Footnote 12 "Commitments and Contingencies" for further details regarding this letter of credit.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Assets Measured at Fair Value on a Recurring Basis Financial instruments recorded at fair value in the financial statements are categorized as follows: • Level 1: Observable inputs that reflect quoted prices for identical assets or liabilities in active markets. • Level 2: Observable inputs, other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3: Unobservable inputs reflecting management's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available. The following table summarizes the assets measured at fair value on a recurring basis as of January 31, 2022 and October 31, 2022 by level within the fair value hierarchy (in thousands): January 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 25,878 $ — $ — $ 25,878 Certificates of deposit — 15,183 — 15,183 Total cash equivalents $ 25,878 $ 15,183 $ — $ 41,061 October 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 8,518 $ — $ — $ 8,518 Certificates of deposit — 15,320 — 15,320 Total cash equivalents $ 8,518 $ 15,320 $ — $ 23,838 During the three and nine months ended October 31, 2021 and 2022, the Company had no transfers between levels of the fair value hierarchy of its assets and liabilities measured at fair value. Fair Value of Other Financial Instruments The carrying amounts of certain financial instruments, including cash held in banks, accounts receivable, accounts payable, accrued liabilities, and other liabilities approximate fair value due to their short-term maturities and are excluded from the fair value tables above.

Property and Equipment

Property and Equipment	9 Months Ended
	Oct. 31, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment, net consisted of the following (in thousands): As of January 31, As of October 31, 2022 2022 Capitalized internal-use software development costs $ 37,088 $ 42,615 Computer equipment and software 4,426 4,802 Leasehold improvements 2,129 2,127 Furniture, vehicles and office equipment 764 761 44,407 50,305 Less accumulated depreciation and amortization (26,823) (30,471) $ 17,584 $ 19,834 Depreciation and amortization expense related to property and equipment was $1.2 million and $1.2 million for the three months ended October 31, 2021 and 2022, respectively, and $3.2 million and $4.0 million for the nine months ended October 31, 2021 and 2022, respectively. The Company capitalized $1.7 million and $1.9 million in software development costs during the three months ended October 31, 2021 and 2022, respectively, and $5.3 million and $5.7 million during the nine months ended October 31, 2021 and 2022, respectively. Amortization of capitalized software development costs was $1.1 million and $1.2 million for the three months ended October 31, 2021 and 2022, respectively, and $2.8 million and $3.7 million for the nine months ended October 31, 2021 and 2022, respectively.

Intangible Assets

Intangible Assets	9 Months Ended
	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets Intangible assets consisted of the following (in thousands): As of January 31, As of October 31, 2022 2022 Intellectual property excluding patents $ 2,458 $ 2,458 Patents 950 950 3,408 3,408 Less accumulated amortization (533) (594) $ 2,875 $ 2,814

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	9 Months Ended
	Oct. 31, 2022
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): As of January 31, As of October 31, 2022 2022 Accrued expenses $ 13,436 $ 14,450 Accrued payroll and benefits 11,494 11,562 Accrued bonus 13,064 7,862 Accrued payroll taxes 7,798 4,609 Accrued commissions 8,119 4,039 Employee stock purchase plan liability 3,840 850 Sales and other taxes payable 518 783 Other accrued liabilities 1,707 1,773 $ 59,976 $ 45,928

Leases

Leases	9 Months Ended
	Oct. 31, 2022
Leases [Abstract]
Leases	Leases The Company leases office space under non-cancelable operating leases with various expiration dates through 2027. These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Components of lease expense are summarized as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2022 2021 2022 Operating lease expense $ 1,695 $ 1,461 $ 4,638 $ 4,944 Short-term lease expense 340 284 934 1,042 Total lease expense $ 2,035 $ 1,745 $ 5,572 $ 5,986 Lease term and discount rate information are summarized as follows: As of October 31, 2022 Weighted average remaining lease term (years) 4.3 Weighted average discount rate 10.0% Maturities of lease liabilities as of October 31, 2022 were as follows (in thousands): Year Ending January 31: 2023 (1) $ 1,232 2024 (1) 5,056 2025 5,111 2026 5,207 2027 5,348 Thereafter 1,797 Total lease payments 23,751 Less imputed interest (4,450) Present value of lease liabilities $ 19,301 (1) Net of $0.5 million and $1.0 million of tenant improvements which are expected to be utilized in fiscal 2023 and 2024, respectively. Cash paid for operating leases was $1.5 million and $2.3 million during the three months ended October 31, 2021 and 2022, respectively, and $3.7 million and $4.7 million during the nine months ended October 31, 2021 and 2022, respectively, and was included in net cash used in operating activities in the condensed consolidated statements of cash flows. In November 2020, the Company entered into an agreement to lease office space from its current landlord. The lease term commenced on May 1, 2021 and is for a period of approximately six years, with rent payments over the term of the lease totaling approximately $23.8 million. At the lease commencement date, the Company classified the lease as an operating lease and recorded a lease liability of $13.6 million with a corresponding right-of-use asset.

Deferred Revenue and Performanc

Deferred Revenue and Performance Obligations	9 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Performance Obligations	Deferred Revenue and Performance Obligations Deferred Revenue Significant changes in the Company's deferred revenue balance for the nine months ended October 31, 2022 were as follows (in thousands): Balance as of January 31, 2022 $ 170,755 Revenue recognized that was included in the deferred revenue balance at the beginning of the period (148,087) Increase due to billings excluding amounts recognized as revenue during the period 138,347 Balance as of October 31, 2022 $ 161,015 Transaction Price Allocated to Remaining Performance Obligations Transaction price allocated to remaining performance obligations represents the remaining amount of revenue the Company expects to recognize from existing non-cancelable contracts, whether billed or unbilled. As of October 31, 2022, approximately $334.8 million of revenue was expected to be recognized from remaining performance obligations for subscription contracts. The Company expects to recognize approximately $215.0 million of this amount during the twelve months following October 31, 2022, with the balance recognized thereafter. As of October 31, 2022, approximately $19.5 million of revenue was expected to be recognized from remaining performance obligations for professional services and other contracts, $15.3 million of which is expected to be recognized during the twelve months following October 31, 2022, and the balance recognized thereafter. Revenue by geographic area is determined by the billing address of the customer. The following table sets forth revenue by geographic area (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2022 2021 2022 United States $ 49,545 $ 61,509 $ 143,574 $ 178,882 Japan 6,287 6,132 18,695 18,731 Other 9,249 11,385 25,699 31,408 Total $ 65,081 $ 79,026 $ 187,968 $ 229,021 Percentage of revenue by geographic area: United States 76 % 78 % 76 % 78 % Japan 10 8 10 8 Other 14 14 14 14 Other than the United States and Japan, no other individual country exceeded 10% of total revenue for the three and nine months ended October 31, 2021 and 2022. As of October 31, 2022, substantially all of the Company’s property and equipment was located in the United States.

Geographic Information

Geographic Information	9 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Geographic Information	Deferred Revenue and Performance Obligations Deferred Revenue Significant changes in the Company's deferred revenue balance for the nine months ended October 31, 2022 were as follows (in thousands): Balance as of January 31, 2022 $ 170,755 Revenue recognized that was included in the deferred revenue balance at the beginning of the period (148,087) Increase due to billings excluding amounts recognized as revenue during the period 138,347 Balance as of October 31, 2022 $ 161,015 Transaction Price Allocated to Remaining Performance Obligations Transaction price allocated to remaining performance obligations represents the remaining amount of revenue the Company expects to recognize from existing non-cancelable contracts, whether billed or unbilled. As of October 31, 2022, approximately $334.8 million of revenue was expected to be recognized from remaining performance obligations for subscription contracts. The Company expects to recognize approximately $215.0 million of this amount during the twelve months following October 31, 2022, with the balance recognized thereafter. As of October 31, 2022, approximately $19.5 million of revenue was expected to be recognized from remaining performance obligations for professional services and other contracts, $15.3 million of which is expected to be recognized during the twelve months following October 31, 2022, and the balance recognized thereafter. Revenue by geographic area is determined by the billing address of the customer. The following table sets forth revenue by geographic area (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2022 2021 2022 United States $ 49,545 $ 61,509 $ 143,574 $ 178,882 Japan 6,287 6,132 18,695 18,731 Other 9,249 11,385 25,699 31,408 Total $ 65,081 $ 79,026 $ 187,968 $ 229,021 Percentage of revenue by geographic area: United States 76 % 78 % 76 % 78 % Japan 10 8 10 8 Other 14 14 14 14 Other than the United States and Japan, no other individual country exceeded 10% of total revenue for the three and nine months ended October 31, 2021 and 2022. As of October 31, 2022, substantially all of the Company’s property and equipment was located in the United States.

Debt

Debt	9 Months Ended
	Oct. 31, 2022
Debt Disclosure [Abstract]
Debt	Debt Credit Facility The Company has a credit facility that permits up to $100.0 million in term loan borrowings, all of which had been drawn as of October 31, 2022. The credit facility is secured by substantially all of the Company's assets. In August 2020, the Company entered into an amendment to the credit facility which extended the maturity date for the outstanding loan from October 1, 2022 to April 1, 2025. Per the amendment, the Company is required to comply with a financial covenant requiring the Company to maintain a minimum balance of unrestricted cash and cash equivalents equal to $10.0 million until the Company’s six-month adjusted cash flow is greater than zero. The amendment also revised the maximum debt ratio financial covenant and included an amendment fee of $5.0 million, which accrues interest at a rate of 9.5% per year. The amendment fee, along with its accrued interest, is to be paid at the earlier of the payment date, maturity date, or the date the loan becomes payable. The credit facility requires interest-only payments until the maturity date. A portion of the interest that accrues on the outstanding principal of each term loan is payable in cash on a monthly basis, which portion accrues at a floating rate equal to the greater of (1) 7% and (2) three-month LIBOR plus 5.5% per year. In the event that LIBOR is unavailable, interest will accrue at a floating rate equal to the greater of (1) 7% and (2) the U.S. prime rate plus 2.75% per year. This interest rate was approximately 9.3% as of October 31, 2022. In addition, a portion of the interest that accrues on the outstanding principal of each term loan is capitalized and added to the principal amount of the outstanding term loan on a monthly basis, which portion accrues at a fixed rate equal to 2.5% per year. During the three months ended October 31, 2021 and 2022, $0.7 million and $0.7 million of interest was capitalized, and $2.1 million and $2.1 million of interest was capitalized during the nine months ended October 31, 2021 and 2022, respectively. The credit facility requires a closing fee of $7.0 million to be paid on the earliest of (1) the date the term loan is prepaid, (2) the term loan maturity date, which is April 1, 2025, and (3) the date the term loan becomes due and payable. Due to the long-term nature of the closing fee, and the amendment fee described above, these fees were recorded at present value as an increase to other liabilities, noncurrent and an increase to debt issuance costs. These liabilities will be accreted to their full value over the term of the loan, with such accretion recorded as interest expense in other expense, net in the condensed consolidated statements of operations. Debt issuance costs are presented as an offset to the outstanding principal balance of the term loans on the condensed consolidated balance sheets and are being amortized as interest expense in other expense, net in the condensed consolidated statements of operations over the term of the loan using the effective interest rate method. The balances in long-term debt consisted of the following (in thousands): As of January 31, As of October 31, 2022 2022 Principal $ 110,599 $ 112,705 Less: unamortized debt issuance costs (6,611) (5,281) Net carrying amount $ 103,988 $ 107,424 The $100.0 million credit facility contains customary conditions to borrowing, events of default and covenants, including covenants that restrict the Company's ability to dispose of assets, make material changes to the nature, control or location of the business, merge with or acquire other entities, incur indebtedness or encumbrances, make distributions to holders of the Company's capital stock, make certain investments or enter into transactions with affiliates. In addition, the Company is required to comply with a financial covenant based on the ratio of outstanding indebtedness to annualized recurring revenue. Under the facility, the maximum ratio is 0.550 on January 31, 2022 and April 30, 2022; 0.525 on July 31, 2022 and October 31, 2022; and 0.500 on January 31, 2023 through the maturity date. The credit facility defines annualized recurring revenue as four times the Company's aggregate revenue for the immediately preceding quarter (net of recurring discounts and discounts for periods greater than one year) less the annual contract value of any customer contracts pursuant to which the Company was advised during such quarter would not be renewed at the end of the current term plus the annual contract value of existing customer contract increases during such quarter. This covenant is measured quarterly on a three-month trailing basis. Upon the occurrence of an event of default, such as non-compliance with covenants, any outstanding principal, interest and fees become due immediately. The Company was in compliance with the covenant terms of the credit facility at January 31, 2022 and October 31, 2022. The Company incurred interest expense of $3.4 million and $4.0 million for the three months ended October 31, 2021 and 2022, respectively, and $10.0 million and $11.0 million for the nine months ended October 31, 2021 and 2022, respectively. Stock Warrants In connection with the credit facility described above, the Company issued warrants which were exercisable for an aggregate of 125,000 shares of Class B common stock at an exercise price of $17.8736 per share. These warrants were net exercised in September 2020, resulting in the issuance of 68,508 shares of Class B common stock. Upon execution of the August 2020 amendment, the Company issued an additional 100,000 fully vested warrants to purchase Class B common stock with an exercise price of $0.01. These warrants were exercised in May 2021, resulting in the issuance of 100,000 shares of Class B common stock. Warrants issued in connection with the credit facility were recorded as an increase to additional paid-in capital with a corresponding increase to debt issuance costs. See Note 13 "Stockholders' Deficit" for further details regarding stock warrants. Structured Payables In June 2022, the Company entered into a structured payables agreement pursuant to which the counterparty assumes responsibility for payables to designated suppliers. The agreement contains an annual limit of an aggregate of $60.0 million, with a maximum allowable outstanding principal balance at any time of $5.0 million. The Company is required to pay interest that accrues at a rate equal to 0.0417% per day after the date on which the Company is required to pay the counterparty with respect to each covered invoice, which interest rate increases to 0.0750% per day at the earlier of 61 days after the respective invoice due date or 121 days after the date of the approved invoice. The Company’s obligations are

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation Liabilities for loss contingencies arising from claims, assessments, litigation, fines, and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred. As discussed more fully in Part II, Item 1 (Legal Proceedings), in November 2019, a securities class action complaint was filed by a purported stockholder of the Company against the Company, certain of the Company's current and former officers and directors, and the underwriters of the Company's June 2018 initial public offering alleging violations of securities laws and seeking unspecified damages. The Company believes this lawsuit is without merit and intends to defend the case vigorously. The Company believes a loss related to this matter is reasonably possible, but is unable to estimate a range of loss, if any, that could result were there to be an adverse final decision in this case. As of the date of this report, the Company does not believe it is probable that this case will result in an unfavorable outcome; however, if an unfavorable outcome were to occur in this case, it is possible that the impact could be material to the Company's results of operations in the period(s) in which any such outcome becomes probable and estimable. The Company is involved in other legal proceedings from time to time arising in the normal course of business. Management believes that the outcome of these proceedings will not have a material impact on the Company's financial condition, results of operations, or liquidity. Warranties and Indemnification The Company’s subscription services are generally warranted to perform materially in accordance with the terms of the applicable customer service order under normal use and circumstances. Additionally, the Company’s arrangements generally include provisions for indemnifying customers against liabilities if its subscription services infringe a third party’s intellectual property rights. Furthermore, the Company may also incur liabilities if it breaches the security or confidentiality obligations in its arrangements. To date, the Company has not incurred significant costs and has not accrued a liability in the accompanying condensed consolidated financial statements as a result of these obligations. The Company has entered into service-level agreements with some of its customers defining levels of uptime reliability and performance and permitting those customers to receive credits for prepaid amounts related to unused subscription services if the Company fails to meet certain of the defined service levels. In very limited instances, the Company allows customers to early terminate their agreements if the Company repeatedly or significantly fails to meet those levels. If the Company repeatedly or significantly fails to meet contracted upon service levels, a contract may require a refund of prepaid unused subscription fees. To date, the Company has not experienced any significant failures to meet defined levels of uptime reliability and performance as set forth in its agreements and, as a result, the Company has not accrued any liabilities related to these agreements in the condensed consolidated financial statements. Letter of Credit In conjunction with a September 2022 amendment to an existing lease agreement, the Company provided a $3.7 million letter of credit to secure the Company’s obligations to pay the landlord for the cost of improvements in excess of the landlord's contribution. No draws have been made on the letter of credit. The letter of credit expires September 2023 and contains an option for renewal. The amount underlying such letter of credit is reflected as restricted cash under cash, cash equivalents, and restricted cash in the Company's condensed consolidated balance sheets as of October 31, 2022. Other Purchase Commitments The Company has also entered into certain non-cancelable contractual commitments related to cloud infrastructure services in the ordinary course of business. There have been no material changes in these commitments as disclosed in the Annual Report on Form 10-K.

Stockholders' Deficit

Stockholders' Deficit	9 Months Ended
	Oct. 31, 2022
Equity [Abstract]
Stockholders' Deficit	Stockholders' Deficit Preferred Stock The Company's Board of Directors has the authority, without further action by the Company's stockholders, to issue up to 10,000,000 shares of preferred stock in one or more series and to fix the rights, preferences, and privileges thereof, including voting rights. As of January 31, 2022 and October 31, 2022, no shares of preferred stock were issued and outstanding. Common Stock The Company has two classes of common stock, Class A and Class B. Each share of Class A common stock is entitled to 40 votes per share and is convertible at any time into one share of Class B common stock. Each share of Class A common stock will convert automatically into one share of Class B common stock upon any transfer, whether or not for value. Each share of Class B common stock is entitled to one vote per share. Holders of Class A common stock and Class B common stock vote together as a single class on all matters (including the election of directors) submitted to a vote of stockholders, unless otherwise required by law or the Company's certificate of incorporation. Subject to preferences that may be applicable to any then-outstanding preferred stock, holders of Class A common stock and Class B common stock are entitled to receive dividends, if any, as may be declared by the Company's board of directors. At January 31, 2022 and October 31, 2022, there were 3,263,659 shares of Class A common stock authorized. There were 3,263,659 shares of Class A common stock issued and outstanding at January 31, 2022 and October 31, 2022. At January 31, 2022 and October 31, 2022, there were 500,000,000 shares of Class B common stock authorized and 29,729,822 and 31,281,307 shares of Class B common stock issued and outstanding, respectively. Class B Common Stock Warrants In connection with the credit facility and a line of credit signed in July 2016, the Company issued warrants to purchase shares of Class B common stock. As of October 31, 2022, there were 3,333 shares of Class B common stock subject to issuance under outstanding warrants, which are exercisable at $34.35 per share.

Equity Incentive Plans

Equity Incentive Plans	9 Months Ended
	Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]
Equity Incentive Plans	Equity Incentive Plans In April 2011, the Company established the 2011 Equity Incentive Plan (2011 Plan), which was amended in September 2011 to provide for the issuance of stock options and other stock-based awards. In June 2018, the Company adopted the 2018 Equity Incentive Plan (2018 Plan). The 2018 Plan provides for the grant of incentive and nonstatutory stock options, restricted stock, RSUs, stock appreciation rights, performance units, and performance shares to employees, consultants, and members of the Company's board of directors. The number of shares available for issuance under the 2018 Plan includes an annual increase on the first day of each fiscal year equal to the least of: (1) 3,500,000 shares; (2) 5% of the outstanding shares of Class A and Class B common stock as of the last day of the immediately preceding fiscal year; and (3) such other amount as the Company's board of directors may determine no later than the last day of the immediately preceding year. During the nine months ended October 31, 2022, the number of shares available for grant under the 2018 Plan was increased by 1,649,674 shares. As of October 31, 2022, there were 4,033,022 shares available for grant under the 2018 Plan. In connection with the IPO, the 2011 Plan was terminated. With the establishment of the 2018 Plan, the Company no longer grants equity-based awards under the 2011 Plan and any shares that expire, terminate, are forfeited or repurchased by the Company, or are withheld by the Company to cover tax withholding obligations, under the 2011 Plan, will become available for future grant under the 2018 Plan. The Company recognized stock-based compensation expense related to its equity incentive plans as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2022 2021 2022 Cost of revenue: Subscription $ 800 $ 667 $ 1,768 $ 2,176 Professional services and other 563 308 1,168 1,339 Sales and marketing 6,718 7,336 15,192 23,284 Research and development 5,363 5,909 10,603 19,196 General and administrative 4,543 4,807 11,596 18,319 Interest expense 176 180 524 550 Total $ 18,163 $ 19,207 $ 40,851 $ 64,864 Stock Options Stock options typically vest over a four-year period and have a term of ten years from the date of grant. No stock options were granted during the three and nine months ended October 31, 2021 and the three and nine months ended October 31, 2022. The following table sets forth the outstanding common stock options and related activity for the nine months ended October 31, 2022: Shares Weighted- Average Exercise Weighted-Average Remaining Contractual Term (years) Aggregate Intrinsic Value (in thousands) Outstanding as of January 31, 2022 963,288 $ 26.16 2.9 $ 20,166 Exercised (47,389) 18.17 Expired (8,990) 37.61 Outstanding as of October 31, 2022 906,909 $ 26.47 2.1 $ 77 Vested and exercisable at October 31, 2022 904,304 $ 26.45 2.1 $ 77 The aggregate intrinsic value of options exercised was $7.4 million and $0.1 million for the three months ended October 31, 2021 and 2022, respectively, and $14.5 million and $1.5 million for the nine months ended October 31, 2021 and 2022, respectively. The intrinsic value represents the excess of the market closing price of the Company's common stock on the date of exercise over the exercise price of each option. The intrinsic value of options as of October 31, 2022 is based on the market closing price of the Company's Class B common stock on that date. As of October 31, 2022, there was $34,000 of unrecognized stock-based compensation expense related to outstanding stock options which is expected to be recognized over a weighted-average period of 0.2 years. Restricted Stock Units Restricted stock units (RSUs) granted under the Plan primarily vest and settle upon the satisfaction of a service-based condition. The service-based condition for these awards is generally satisfied over three one During the three months ended April 30, 2022 the Company granted 71,667 PSUs with both a market and service-based condition. The PSUs are eligible to vest in three trading days of $60.00 per share, $70.00 per share, and $90.00 per share, respectively. The grant date fair values of the PSUs granted were $36.07 per share, $33.98 per share, and $30.26 per share, respectively, as determined by a Monte Carlo simulation model. The following table sets forth the outstanding RSUs and related activity for the nine months ended October 31, 2022: Number of Shares Weighted- Average Grant Date Fair Value Outstanding as of January 31, 2022 4,338,619 $ 55.40 Granted 2,005,478 43.25 Vested (1,339,137) 51.82 Canceled (1,008,921) 53.35 Outstanding as of October 31, 2022 3,996,039 $ 51.01 As of October 31, 2022, there was $179.0 million of unrecognized stock-based compensation expense related to outstanding RSUs which is expected to be recognized over a weighted-average period of 2.7 years. In March 2022, the Company paid out certain fiscal 2022 bonuses in the form of vested RSUs instead of cash, resulting in the issuance of approximately 90,000 shares of the Company's Class B common stock. The Company recognized $3.6 million of stock-based compensation related to these bonuses during the three months ended April 30, 2022. In April 2022, the Company modified and accelerated the vesting of awards for certain employees, resulting in the issuance of approximately 56,000 shares of the Company's Class B common stock. The Company recognized $2.6 million of stock-based compensation related to these modifications during the three months ended April 30, 2022. Employee Stock Purchase Plan In June 2018, the Company's board of directors adopted the ESPP. The number of shares of Class B common stock available for issuance under the ESPP increases on the first day of each fiscal year equal to the least of: (1) 1,050,000 shares of Class B common stock, (2) 1.5% of the outstanding shares of Class A and Class B common stock of the Company on the last day of the immediately preceding fiscal year, and (3) such other amount as the administrator of the ESPP may determine on or before the last day of the immediately preceding year. During the nine months ended October 31, 2022, the number of shares available under the ESPP was increased by 164,967 shares. As of October 31, 2022, there were 307 shares available under the ESPP. The ESPP generally provides for consecutive overlapping 12-month offering periods comprising two six-month purchase periods. The offering periods are scheduled to start on the first trading day on or after April 1 and October 1 of each year. The ESPP is intended to qualify as a tax-qualified plan under Section 423 of the Internal Revenue Code and permits participants to elect to purchase shares of Class B common stock through payroll deductions of up to 25% of their eligible compensation. Under the ESPP, a participant may purchase a maximum of 300 shares during each purchase period. Amounts deducted and accumulated by the participant will be used to purchase shares of Class B common stock at the end of each purchase period. The purchase price of the shares will be 85% of the lower of the fair market value of Class B common stock on the first trading day of each offering period or the fair market value of Class B common stock on the applicable exercise date. If the fair market value of a share of Class B common stock on the exercise date of an offering period is less than it was on the first trading day of that offering period, participants automatically will be withdrawn from that offering period following their purchase of shares on the exercise date and will be re-enrolled in a new offering period. Participants may end their participation at any time during an offering period and will be paid their accrued contributions that have not yet been used to purchase shares of Class B common stock. Participation ends automatically upon termination of employment. As of October 31, 2022, a total of approximately 368,369 shares were issuable to employees based on estimated shares available and contribution elections made under the ESPP. Shares available were estimated assuming that the plan will be

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company calculated the year-to-date income tax provision by applying the estimated annual effective tax rate to the year-to-date pre-tax income for each applicable jurisdiction and adjusted for discrete tax items in the period. The Company's income tax expense was $62,000 and $167,000 for the three months ended October 31, 2021 and 2022, respectively, and $89,000 and $567,000 for the nine months ended October 31, 2021 and 2022, respectively. The income tax expense for these periods was primarily attributable to foreign taxes. For the periods presented, the difference between the U.S. statutory rate and the Company's effective tax rate is primarily due to the full valuation allowance on its U.S. tax assets. The effective tax rate is also impacted by earnings realized in foreign jurisdictions.

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The Company computes net loss per share using the two-class method required for multiple classes of common stock and participating securities. The rights, including the liquidation and dividend rights, of the Class A common stock and Class B common stock are substantially identical, other than voting rights. Accordingly, the Class A common stock and Class B common stock share equally in the Company’s net losses. The following table sets forth the calculation of basic and diluted net loss per share during the periods presented (in thousands, except per share amounts): Three Months Ended October 31, 2021 2022 Class A Class B Class A Class B Numerator: Net loss $ (2,876) $ (25,637) $ (2,250) $ (21,461) Denominator: Weighted-average number of shares used in 3,264 29,099 3,264 31,128 Net loss per share, basic and diluted $ (0.88) $ (0.88) $ (0.69) $ (0.69) Nine Months Ended October 31, 2021 2022 Class A Class B Class A Class B Numerator: Net loss $ (7,077) $ (61,780) $ (8,257) $ (77,481) Denominator: Weighted-average number of shares used in 3,264 28,494 3,264 30,629 Net loss per share, basic and diluted $ (2.17) $ (2.17) $ (2.53) $ (2.53) Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential common shares outstanding would have been anti-dilutive. The weighted-average impact of potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive was as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2022 2021 2022 Options to purchase common stock 792 6 812 204 Restricted stock units 2,240 137 2,369 490 Employee stock purchase program 133 24 433 30 Common stock warrants 2 — 60 — 3,167 167 3,674 724

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Basis of Accounting	The accompanying unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP). All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year ends on January 31.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. The Company bases its estimates on historical experience and on other assumptions that its management believes are reasonable under the circumstances. Actual results could differ from those estimates. The Company’s estimates and judgments include the determination of standalone selling prices for the Company’s services, which are used to determine revenue recognition for arrangements with multiple performance obligations; the amortization period for deferred contract acquisition costs; valuation of the Company’s stock-based compensation and related service period; useful lives of fixed assets; capitalization and estimated useful life of internal-use software; the incremental borrowing rate used to calculate the present value of capitalized leases; valuation estimates used when evaluating impairment of long-lived and intangible assets including goodwill; and the allowance for doubtful accounts.
Foreign Currency	Foreign Currency The functional currencies of the Company’s foreign subsidiaries are the respective local currencies. The cumulative effect of translation adjustments arising from the use of differing exchange rates from period to period is included in
Segment Information	Segment Information The Company operates as one operating segment. The Company’s chief operating decision maker is its chief executive officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance and allocating resources.
Cash and Cash Equivalents and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash Cash and cash equivalents may consist of cash on hand, money market funds and highly liquid investments purchased with an original maturity date of 90 days or less from the date of purchase. The fair value of cash equivalents approximated their carrying value as of January 31, 2022 and October 31, 2022. Restricted cash relates to an outstanding letter of credit established in conjunction with an amendment to an existing lease agreement.
Accounts Receivables	Accounts ReceivableAccounts receivable are recorded at the invoiced amount (net of allowance), do not require collateral, and do not bear interest. The Company’s payment terms generally provide that customers pay within 30 days of the invoice date.
Allowance for Doubtful Accounts	The Company maintains an allowance for doubtful accounts and expected credit losses for amounts the Company does not expect to collect. In establishing the required allowance, management considers historical losses, current market conditions, customers’ financial condition and credit quality, the age of the receivables, and current payment patterns. Account balances are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.
Contract Acquisition Costs and Revenue Recognition	Contract Acquisition Costs Contract acquisition costs, net are stated at cost net of accumulated amortization and primarily consist of deferred sales commissions, which are considered incremental and recoverable costs of obtaining a contract with a customer. Contract acquisition costs for initial contracts are deferred and then amortized on a straight-line basis over the period of benefit, which the Company has determined to be approximately four years. The period of benefit is determined by taking into consideration contractual terms, expected customer life, changes in the Company's technology and other factors. Contract acquisition costs for renewal contracts are not commensurate with contract acquisition costs for initial contracts and are recorded as expense when incurred if the period of benefit is one year or less. If the period of benefit is greater than one year, costs are deferred and then amortized on a straight-line basis over the period of benefit, which the Company has determined to be two years. Contract acquisition costs related to professional services and other performance obligations with a period of benefit of one year or less are recorded as expense when incurred. Amortization of contract acquisition costs is included in sales and marketing expenses in the accompanying condensed consolidated statements of operations. Revenue Recognition The Company derives revenue primarily from subscriptions to its cloud-based platform and professional services. Revenue is recognized when control of these services is transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those services, net of sales taxes. For sales through channel partners, the Company considers the channel partner to be the end customer for the purposes of revenue recognition as the Company's contractual relationships with channel partners do not depend on the sale of the Company's services to their customers and payment from the channel partner is not contingent on receiving payment from their customers. The Company's contractual relationships with channel partners do not allow returns, rebates, or price concessions. The price of subscriptions is generally fixed at contract inception and therefore, the Company's contracts do not contain a significant amount of variable consideration. Revenue recognition is determined through the following steps: • Identification of the contract, or contracts, with a customer • Identification of the performance obligations in the contract • Determination of the transaction price • Allocation of the transaction price to the performance obligations in the contract • Recognition of revenue when, or as, performance obligations are satisfied Subscription Revenue Subscription revenue primarily consists of fees paid by customers to access the Company’s cloud-based platform, including support services. The majority of the Company's subscription agreements have multi-year contractual terms and a smaller percentage have annual contractual terms. Revenue is recognized ratably over the related contractual term beginning on the date that the platform is made available to a customer. Access to the platform represents a series of distinct services as the Company continually provides access to and fulfills its obligation to the end customer over the subscription term. The series of distinct services represents a single performance obligation that is satisfied over time. The Company recognizes revenue ratably because the customer receives and consumes the benefits of the platform throughout the contract period. The Company's contracts are generally non-cancelable. Professional Services and Other Revenue Professional services revenue consists of implementation services sold with new subscriptions as well as professional services sold separately. Other revenue includes training and education. Professional services arrangements are billed in advance, and revenue from these arrangements is recognized as the services are provided, generally based on hours incurred. Training and education revenue is also recognized as the services are provided. Contracts with Multiple Performance Obligations Most of the Company's contracts with new customers contain multiple performance obligations, generally consisting of subscriptions and professional services. For these contracts, individual performance obligations are accounted for separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices are determined based on historical standalone selling prices, taking into consideration overall pricing objectives, market conditions and other factors, including contract value, customer demographics, platform tier, and the number and types of users within the contract. Deferred Revenue The Company's contracts are typically billed annually in advance. Deferred revenue includes amounts collected or billed in excess of revenue recognized. Deferred revenue is recognized as revenue as the related performance obligations are satisfied. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as a current liability and the remaining portion is recorded as a noncurrent liability. Cost of Revenue Cost of subscription revenue consists primarily of third-party hosting services and data center capacity; employee-related costs directly associated with cloud infrastructure and customer support personnel, including salaries, benefits, bonuses and stock-based compensation; amortization expense associated with capitalized software development costs; depreciation expense associated with computer equipment and software; certain fees paid to various third parties for the use of their technology and services; and allocated overhead. Allocated overhead includes items such as information technology infrastructure, rent, and employee benefit costs.
Property and Equipment	Property and Equipment, Net Property and equipment, net, are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets or over the related lease terms (if shorter). Repairs and maintenance costs are expensed as incurred. The estimated useful lives of property and equipment are as follows: Computer equipment and software 2-3 years Furniture, vehicles and office equipment 3 years Leasehold improvements Shorter of remaining lease term or estimated useful life
Leases	Leases At the inception of a contract, the Company determines whether the contract is or contains a lease. Leases with a term greater than one year are recognized on the balance sheet as right-of-use (ROU) assets and lease liabilities. The Company has elected the short-term leases practical expedient which allows any leases with a term of 12 months or less to be considered short-term and thus not have an ROU asset or lease liability recognized on the balance sheet. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As these leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate incurred to borrow on a collateralized basis over a similar term and amount equal to the lease payments in a similar economic environment. The operating lease ROU asset also includes any lease payments made in advance of lease expense and excludes lease incentives and initial direct costs incurred. Certain lease terms include options to terminate or extend the lease for periods of one The Company has lease agreements with lease and non-lease components which the Company has elected to account for as a single lease component. On the lease commencement date, the Company establishes assets and liabilities for the present value of estimated future costs to retire long-lived assets at the termination or expiration of a lease. Such assets are depreciated over the lease term to operating expense. Income from subleases is recorded in other expense, net in the accompanying condensed consolidated statements of operations.
Capitalized Internal-Use Software Costs	Capitalized Internal-Use Software Costs The Company capitalizes certain costs related to development of its platform incurred during the application development stage. Costs related to preliminary project activities and post-implementation activities are expensed as incurred. Maintenance and training costs are also expensed as incurred. Capitalized costs are included in property and equipment.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill represents the excess of the purchase price in a business combination over the fair value of net tangible and intangible assets acquired. Goodwill and indefinite-lived intangible assets are not amortized, but rather tested for impairment at least annually on November 1 or more often if and when circumstances indicate that the carrying value may not be recoverable. Finite-lived intangible assets are amortized over their useful lives. Goodwill is tested for impairment based on reporting units. The Company periodically reevaluates the business and has determined that it continues to operate in one segment, which is also considered the sole reporting unit. Therefore, goodwill is tested for impairment at the consolidated level. The Company reviews its long-lived assets, including property and equipment, finite-lived intangible assets, and ROU assets for impairment whenever an event or change in facts and circumstances indicates that their carrying amounts may not be recoverable. Recoverability of these assets is measured by comparing the carrying amount to the estimated undiscounted future cash flows expected to be generated. If the carrying amount exceeds the undiscounted cash flows, the assets are determined to be impaired and an impairment charge is recognized as the amount by which the carrying amount exceeds fair value. There was no goodwill acquired and no impairment charges for goodwill or long-lived assets recorded during the periods presented.
Advertising Costs	Advertising CostsAdvertising costs are expensed as incurred.
Research and Development	Research and Development Research and development expenses consist primarily of employee-related costs for the design and development of the Company's platform, contractor costs to supplement staff levels, third-party web services, consulting services, and allocated overhead. Research and development expenses, other than software development costs qualifying for capitalization, are expensed as incurred.
Stock-Based Compensation	Stock-Based Compensation The Company has granted stock-based awards, consisting of stock options and restricted stock units, to its employees, certain consultants and certain members of its board of directors. The Company records stock-based compensation based on the grant date fair value of the awards, which include stock options and restricted stock units, and recognizes the fair value of those awards as expense using the straight-line method over the requisite service period of the award. For restricted stock units that contain market conditions, the Company recognizes stock-based compensation based on the estimated grant date fair value of market condition awards using a Monte Carlo simulation, and the awards are expensed over the service period using an accelerated attribution method. Stock-based compensation expense related to purchase rights issued under the 2018 Employee Stock Purchase Plan (ESPP) is based on the Black-Scholes option-pricing model fair value of the estimated number of awards as of the beginning of the offering period. Stock-based compensation expense is recognized using the straight-line method over the offering period.
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with the liability method of accounting for income taxes. Under this method, the Company recognizes a liability or asset for the deferred income tax consequences of all temporary differences between the tax basis of assets and liabilities and their reported amounts in the condensed consolidated financial statements that will result in taxable or deductible amounts in future years when the reported amounts of the assets and liabilities are recovered or settled. These deferred income tax assets or liabilities are measured using the enacted tax rates that will be in effect when the differences are expected to affect taxable income. Valuation allowances are provided when it is more-likely-than-not that some or all of the deferred income tax assets may not be realized. In assessing the need for a valuation allowance, the Company has considered its historical levels of income, expectations of future taxable income and ongoing tax planning strategies. Because of the uncertainty of the realization of its deferred tax assets, the Company has a full valuation allowance for domestic net deferred tax assets, including net operating loss carryforwards, and tax credits related primarily to research and development. Realization of its deferred tax assets is dependent primarily upon future U.S. taxable income. Tax positions are recognized in the condensed consolidated financial statements when it is more-likely-than-not the position will be sustained upon examination by the tax authorities. The Company’s policy for recording interest and penalties related to income taxes, including uncertain tax positions, is to record such items as a component of the provision for income taxes.
Concentration of Credit Risk	Concentrations of Credit Risk and Significant Customers Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. Cash denominated in currencies other than the United States dollar represented 20% and 21% of total cash, cash equivalents, and restricted cash as of January 31, 2022 and October 31, 2022, respectively. The Company maintains its cash accounts with financial institutions where, at times, deposits exceed federal insured limits. The Company may invest its excess cash in money market funds, certificates of deposit, or in short-term investments consisting of highly-rated debt securities.
Concentration of Significant Customers	The Company is primarily dependent upon third parties in order to meet the uptime and performance requirements of its customers. Any disruption of or interference with the Company's use of these third parties would impact operations.
Net Loss Per Share	Net Loss per Share The Company computes net loss per share using the two-class method required for multiple classes of common stock and participating securities. The rights, including the liquidation and dividend rights, of the Class A common stock and Class B common stock are substantially identical, other than voting rights. Accordingly, the Class A common stock and Class B common stock share equally in the Company’s net losses. Basic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period increased by common shares that could be issued upon conversion or exercise of other outstanding securities to the extent those additional common shares would be dilutive. The dilutive effect of potentially dilutive securities is reflected in diluted net loss per share by application of the treasury stock method. During periods when the Company is in a net loss position, basic net loss per share is the same as diluted net loss per share as the effects of potentially dilutive securities are anti-dilutive.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In September 2022, the FASB issued ASU No. 2022-04, Liabilities - Supplier Finance Programs (Topic 450-50) : Disclosure of Supplier Finance Program Obligations , which requires entities that use supplier finance programs in connection with the purchase of goods and services to make certain annual disclosures about the the key terms of the programs and information about the obligations outstanding at the end of the reporting period, including a rollforward of those obligations. The guidance does not affect the recognition, measurement or financial statement presentation of supplier finance program obligations. The amendments in ASU 2022-04 are effective for all entities for fiscal years beginning after December 15, 2022 on a retrospective basis, including interim periods within those fiscal years, except for the requirement to disclose rollforward information, which is effective prospectively for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company is currently evaluating the new guidance to determine the impact it may have on its consolidated financial statements and related disclosures.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Oct. 31, 2022
Accounting Policies [Abstract]
Schedule of Estimated Useful Lives of Property, Plant and Equipment	The estimated useful lives of property and equipment are as follows: Computer equipment and software 2-3 years Furniture, vehicles and office equipment 3 years Leasehold improvements Shorter of remaining lease term or estimated useful life Property and equipment, net consisted of the following (in thousands): As of January 31, As of October 31, 2022 2022 Capitalized internal-use software development costs $ 37,088 $ 42,615 Computer equipment and software 4,426 4,802 Leasehold improvements 2,129 2,127 Furniture, vehicles and office equipment 764 761 44,407 50,305 Less accumulated depreciation and amortization (26,823) (30,471) $ 17,584 $ 19,834

Cash, Cash Equivalents, and R_2

Cash, Cash Equivalents, and Restricted Cash (Tables)	9 Months Ended
	Oct. 31, 2022
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents and Short-Term Investments	The amortized cost and estimated fair value of the Company’s cash, cash equivalents, and restricted cash as of January 31, 2022 and October 31, 2022 were as follows (in thousands): January 31, 2022 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value Cash $ 42,500 $ — $ — $ 42,500 Cash equivalents: Money market funds 25,878 — — 25,878 Certificates of deposit 15,183 — — 15,183 Total cash and cash equivalents $ 83,561 $ — $ — $ 83,561 October 31, 2022 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value Cash $ 43,544 $ — $ — $ 43,544 Cash equivalents: Money market funds 8,518 — — 8,518 Certificates of deposit 15,320 — — 15,320 Restricted cash (1) 3,700 — — 3,700 Total cash, cash equivalents, and restricted cash $ 71,082 $ — $ — $ 71,082 (1) Related to an outstanding letter of credit. See Footnote 12 "Commitments and Contingencies" for further details regarding this letter of credit.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 31, 2022
Fair Value Disclosures [Abstract]
Summary of Assets Measured at Fair Value on Recurring Basis	The following table summarizes the assets measured at fair value on a recurring basis as of January 31, 2022 and October 31, 2022 by level within the fair value hierarchy (in thousands): January 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 25,878 $ — $ — $ 25,878 Certificates of deposit — 15,183 — 15,183 Total cash equivalents $ 25,878 $ 15,183 $ — $ 41,061 October 31, 2022 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 8,518 $ — $ — $ 8,518 Certificates of deposit — 15,320 — 15,320 Total cash equivalents $ 8,518 $ 15,320 $ — $ 23,838

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Oct. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	The estimated useful lives of property and equipment are as follows: Computer equipment and software 2-3 years Furniture, vehicles and office equipment 3 years Leasehold improvements Shorter of remaining lease term or estimated useful life Property and equipment, net consisted of the following (in thousands): As of January 31, As of October 31, 2022 2022 Capitalized internal-use software development costs $ 37,088 $ 42,615 Computer equipment and software 4,426 4,802 Leasehold improvements 2,129 2,127 Furniture, vehicles and office equipment 764 761 44,407 50,305 Less accumulated depreciation and amortization (26,823) (30,471) $ 17,584 $ 19,834

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-lived Intangible Assets	Intangible assets consisted of the following (in thousands): As of January 31, As of October 31, 2022 2022 Intellectual property excluding patents $ 2,458 $ 2,458 Patents 950 950 3,408 3,408 Less accumulated amortization (533) (594) $ 2,875 $ 2,814
Schedule of Indefinite-Lived Intangible Assets	Intangible assets consisted of the following (in thousands): As of January 31, As of October 31, 2022 2022 Intellectual property excluding patents $ 2,458 $ 2,458 Patents 950 950 3,408 3,408 Less accumulated amortization (533) (594) $ 2,875 $ 2,814

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Oct. 31, 2022
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): As of January 31, As of October 31, 2022 2022 Accrued expenses $ 13,436 $ 14,450 Accrued payroll and benefits 11,494 11,562 Accrued bonus 13,064 7,862 Accrued payroll taxes 7,798 4,609 Accrued commissions 8,119 4,039 Employee stock purchase plan liability 3,840 850 Sales and other taxes payable 518 783 Other accrued liabilities 1,707 1,773 $ 59,976 $ 45,928

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 31, 2022
Leases [Abstract]
Components of Lease Expense and Lease Term and Discount Rate Information	Components of lease expense are summarized as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2022 2021 2022 Operating lease expense $ 1,695 $ 1,461 $ 4,638 $ 4,944 Short-term lease expense 340 284 934 1,042 Total lease expense $ 2,035 $ 1,745 $ 5,572 $ 5,986 Lease term and discount rate information are summarized as follows: As of October 31, 2022 Weighted average remaining lease term (years) 4.3 Weighted average discount rate 10.0%
Maturities of Lease Liabilities	Maturities of lease liabilities as of October 31, 2022 were as follows (in thousands): Year Ending January 31: 2023 (1) $ 1,232 2024 (1) 5,056 2025 5,111 2026 5,207 2027 5,348 Thereafter 1,797 Total lease payments 23,751 Less imputed interest (4,450) Present value of lease liabilities $ 19,301 (1) Net of $0.5 million and $1.0 million of tenant improvements which are expected to be utilized in fiscal 2023 and 2024, respectively.

Deferred Revenue and Performa_2

Deferred Revenue and Performance Obligations (Tables)	9 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Changes in Deferred Revenue Balance	Significant changes in the Company's deferred revenue balance for the nine months ended October 31, 2022 were as follows (in thousands): Balance as of January 31, 2022 $ 170,755 Revenue recognized that was included in the deferred revenue balance at the beginning of the period (148,087) Increase due to billings excluding amounts recognized as revenue during the period 138,347 Balance as of October 31, 2022 $ 161,015

Geographic Information (Tables)

Geographic Information (Tables)	9 Months Ended
	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Revenue by Geographic Area	The following table sets forth revenue by geographic area (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2022 2021 2022 United States $ 49,545 $ 61,509 $ 143,574 $ 178,882 Japan 6,287 6,132 18,695 18,731 Other 9,249 11,385 25,699 31,408 Total $ 65,081 $ 79,026 $ 187,968 $ 229,021 Percentage of revenue by geographic area: United States 76 % 78 % 76 % 78 % Japan 10 8 10 8 Other 14 14 14 14

Debt (Tables)

Debt (Tables)	9 Months Ended
	Oct. 31, 2022
Debt Disclosure [Abstract]
Schedule of Long-term Debt	The balances in long-term debt consisted of the following (in thousands): As of January 31, As of October 31, 2022 2022 Principal $ 110,599 $ 112,705 Less: unamortized debt issuance costs (6,611) (5,281) Net carrying amount $ 103,988 $ 107,424

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	9 Months Ended
	Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Recognized Stock-based Compensation Expense	The Company recognized stock-based compensation expense related to its equity incentive plans as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2022 2021 2022 Cost of revenue: Subscription $ 800 $ 667 $ 1,768 $ 2,176 Professional services and other 563 308 1,168 1,339 Sales and marketing 6,718 7,336 15,192 23,284 Research and development 5,363 5,909 10,603 19,196 General and administrative 4,543 4,807 11,596 18,319 Interest expense 176 180 524 550 Total $ 18,163 $ 19,207 $ 40,851 $ 64,864
Schedule of Outstanding Stock Options and Related Activity	The following table sets forth the outstanding common stock options and related activity for the nine months ended October 31, 2022: Shares Weighted- Average Exercise Weighted-Average Remaining Contractual Term (years) Aggregate Intrinsic Value (in thousands) Outstanding as of January 31, 2022 963,288 $ 26.16 2.9 $ 20,166 Exercised (47,389) 18.17 Expired (8,990) 37.61 Outstanding as of October 31, 2022 906,909 $ 26.47 2.1 $ 77 Vested and exercisable at October 31, 2022 904,304 $ 26.45 2.1 $ 77
Schedule of Outstanding RSUs and Related Activity	The following table sets forth the outstanding RSUs and related activity for the nine months ended October 31, 2022: Number of Shares Weighted- Average Grant Date Fair Value Outstanding as of January 31, 2022 4,338,619 $ 55.40 Granted 2,005,478 43.25 Vested (1,339,137) 51.82 Canceled (1,008,921) 53.35 Outstanding as of October 31, 2022 3,996,039 $ 51.01

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Oct. 31, 2022
Earnings Per Share [Abstract]
Schedule of Computation of Net Loss Per Share	The following table sets forth the calculation of basic and diluted net loss per share during the periods presented (in thousands, except per share amounts): Three Months Ended October 31, 2021 2022 Class A Class B Class A Class B Numerator: Net loss $ (2,876) $ (25,637) $ (2,250) $ (21,461) Denominator: Weighted-average number of shares used in 3,264 29,099 3,264 31,128 Net loss per share, basic and diluted $ (0.88) $ (0.88) $ (0.69) $ (0.69) Nine Months Ended October 31, 2021 2022 Class A Class B Class A Class B Numerator: Net loss $ (7,077) $ (61,780) $ (8,257) $ (77,481) Denominator: Weighted-average number of shares used in 3,264 28,494 3,264 30,629 Net loss per share, basic and diluted $ (2.17) $ (2.17) $ (2.53) $ (2.53)
Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share	The weighted-average impact of potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive was as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2021 2022 2021 2022 Options to purchase common stock 792 6 812 204 Restricted stock units 2,240 137 2,369 490 Employee stock purchase program 133 24 433 30 Common stock warrants 2 — 60 — 3,167 167 3,674 724

Overview and Basis of Present_2

Overview and Basis of Presentation (Details)	9 Months Ended
	Oct. 31, 2022 segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating segments	1

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details)	3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 31, 2022 USD ($)	Oct. 31, 2021 USD ($)	Oct. 31, 2022 USD ($) segment	Oct. 31, 2021 USD ($)	Jan. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Amortization period for capitalized contract acquisition costs	4 years		4 years
Amortization of expense related to contract acquisition costs	$ 4,200,000	$ 4,000,000	$ 12,825,000	$ 11,779,000
Impairment charge in relation to contract acquisition costs	0	0	$ 0	0
Number of operating segments | segment			1
Goodwill acquired	0	0	$ 0	0
Impairment charges for goodwill or long-lived assets	0	0	0	0
Advertising expense	$ 3,000,000	$ 2,400,000	$ 10,700,000	$ 8,000,000
Minimum
Finite-Lived Intangible Assets [Line Items]
Lease renewal terms	1 year		1 year
Maximum
Finite-Lived Intangible Assets [Line Items]
Lease renewal terms	3 years		3 years
Foreign Currency Cash Concentration Risk | Cash, cash equivalents, and restricted cash | Credit Risk
Finite-Lived Intangible Assets [Line Items]
Concentration risk percentage			21%		20%
Customer Concentration Risk | Accounts Receivable | One customer
Finite-Lived Intangible Assets [Line Items]
Concentration risk percentage			12%
Capitalized internal-use software development costs
Finite-Lived Intangible Assets [Line Items]
Useful lives of capitalized internal-use software			3 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Property and Equipment (Details)	9 Months Ended
	Oct. 31, 2022
Computer equipment and software | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives of property and equipment	2 years
Computer equipment and software | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives of property and equipment	3 years
Furniture, vehicles and office equipment
Property, Plant and Equipment [Line Items]
Estimated useful lives of property and equipment	3 years

Cash, Cash Equivalents, and R_3

Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022	Oct. 31, 2021	Jan. 31, 2021
Cash and Cash Equivalents [Line Items]
Restricted cash	$ 3,700
Cash, cash equivalents, and restricted cash	71,082	$ 83,561	$ 84,245	$ 90,794
Cash
Cash and Cash Equivalents [Line Items]
Cash	43,544	42,500
Money market funds
Cash and Cash Equivalents [Line Items]
Cash equivalents	8,518	25,878
Certificates of deposit
Cash and Cash Equivalents [Line Items]
Cash equivalents	$ 15,320	$ 15,183

Fair Value Measurements - Asset

Fair Value Measurements - Assets Measured at Fair Value on Recurring Basis (Details) - Recurring Basis - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	$ 23,838	$ 41,061
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	8,518	25,878
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	15,320	15,183
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	8,518	25,878
Money market funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	8,518	25,878
Money market funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Money market funds | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	15,320	15,183
Certificates of deposit | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Certificates of deposit | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	15,320	15,183
Certificates of deposit | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	$ 0	$ 0

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jan. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 50,305		$ 50,305		$ 44,407
Less accumulated depreciation and amortization	(30,471)		(30,471)		(26,823)
Property and equipment, net	19,834		19,834		17,584
Depreciation, excluding exchange rate effect	1,200	$ 1,200	4,000	$ 3,200
Software development costs capitalized	1,900	1,700	5,700	5,300
Capitalized software development costs amortized	1,200	$ 1,100	3,700	$ 2,800
Capitalized internal-use software development costs
Property, Plant and Equipment [Line Items]
Property and equipment, gross	42,615		42,615		37,088
Computer equipment and software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	4,802		4,802		4,426
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,127		2,127		2,129
Furniture, vehicles and office equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 761		$ 761		$ 764

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 3,408	$ 3,408
Less accumulated amortization	(594)	(533)
Intangible assets, net	2,814	2,875
Intellectual property excluding patents
Indefinite-lived Intangible Assets [Line Items]
Intellectual property excluding patents	2,458	2,458
Patents
Finite-Lived Intangible Assets [Line Items]
Patents	$ 950	$ 950

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Amortization of intangible assets	$ 20	$ 154	$ 60	$ 461
Patents
Finite-Lived Intangible Assets [Line Items]
Weighted-average amortization period			4 years 6 months

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Payables and Accruals [Abstract]
Accrued expenses	$ 14,450	$ 13,436
Accrued payroll and benefits	11,562	11,494
Accrued bonus	7,862	13,064
Accrued payroll taxes	4,609	7,798
Accrued commissions	4,039	8,119
Employee stock purchase plan liability	850	3,840
Sales and other taxes payable	783	518
Other accrued liabilities	1,773	1,707
Accrued expenses and other current liabilities	$ 45,928	$ 59,976

Leases - Components of Lease Ex

Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Leases [Abstract]
Operating lease expense	$ 1,461	$ 1,695	$ 4,944	$ 4,638
Short-term lease expense	284	340	1,042	934
Total lease expense	$ 1,745	$ 2,035	$ 5,986	$ 5,572
Weighted average remaining lease term (years)	4 years 3 months 18 days		4 years 3 months 18 days
Weighted average discount rate	10%		10%

Leases - Maturities of Lease Li

Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2022	May 01, 2021
Leases [Abstract]
2023	$ 1,232
2024	5,056
2025	5,111
2026	5,207
2027	5,348
Thereafter	1,797
Total lease payments	23,751
Less imputed interest	(4,450)
Operating lease liabilities	$ 19,301	$ 13,600

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		72 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Apr. 30, 2027	Jan. 31, 2022	May 01, 2021
Subsequent Event [Line Items]
Tenant improvements to be utilized in 2022	$ 500		$ 500
Tenant improvements to be utilized in 2023	1,000		1,000
Cash paid for operating lease liabilities	2,300	$ 1,500	4,700	$ 3,700
Lease term							6 years
Operating lease liabilities	19,301		19,301				$ 13,600
Right-of-use assets	$ 14,871		$ 14,871			$ 16,392	$ 13,600
Expected
Subsequent Event [Line Items]
Cash paid for operating lease liabilities					$ 23,800

Deferred Revenue and Performa_3

Deferred Revenue and Performance Obligations (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2022 USD ($)
Contract with Customer, Liability, Increase (Decrease) [Roll Forward]
Deferred revenue, beginning balance	$ 170,755
Revenue recognized that was included in the deferred revenue balance at the beginning of the period	(148,087)
Increase due to billings excluding amounts recognized as revenue during the period	138,347
Deferred revenue, ending balance	$ 161,015

Deferred Revenue and Performa_4

Deferred Revenue and Performance Obligations - Narrative (Details) $ in Millions	Oct. 31, 2022 USD ($)
Subscription
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations	$ 334.8
Subscription | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations	$ 215
Expected satisfaction period for remaining revenue performance obligations	12 months
Professional services and other
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations	$ 19.5
Professional services and other | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations	$ 15.3
Expected satisfaction period for remaining revenue performance obligations	12 months

Geographic Information - Revenu

Geographic Information - Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Concentration Risk [Line Items]
Total revenue	$ 79,026	$ 65,081	$ 229,021	$ 187,968
United States
Concentration Risk [Line Items]
Total revenue	$ 61,509	$ 49,545	$ 178,882	$ 143,574
United States | Revenue | Geographic concentration
Concentration Risk [Line Items]
Percentage of revenue by geographic area (percent)	78%	76%	78%	76%
Japan
Concentration Risk [Line Items]
Total revenue	$ 6,132	$ 6,287	$ 18,731	$ 18,695
Japan | Revenue | Geographic concentration
Concentration Risk [Line Items]
Percentage of revenue by geographic area (percent)	8%	10%	8%	10%
Other
Concentration Risk [Line Items]
Total revenue	$ 11,385	$ 9,249	$ 31,408	$ 25,699
Other | Revenue | Geographic concentration
Concentration Risk [Line Items]
Percentage of revenue by geographic area (percent)	14%	14%	14%	14%

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Jun. 30, 2022	Jan. 31, 2022	Sep. 30, 2020	Aug. 31, 2020	Jul. 31, 2020
Line of Credit Facility [Line Items]
Amount outstanding	$ 107,424,000		$ 107,424,000			$ 103,988,000
Class B Common Stock
Line of Credit Facility [Line Items]
Number of shares that can be purchased (shares)	3,333		3,333
Credit Facility Maturing April 2025
Line of Credit Facility [Line Items]
Interest expense incurred	$ 4,000,000	$ 3,400,000	$ 11,000,000	$ 10,000,000
Other payables | Structured Payables
Line of Credit Facility [Line Items]
Interest expense incurred	0		0
Annual limit					$ 60,000,000
Maximum allowable outstanding principal balance					$ 5,000,000
Daily interest rate					0.0417%
Daily interest rate at earlier of 61 days after respective invoice due date and 121 days after date of approved invoice					0.075%
Collateral amount					$ 6,000,000
Amount outstanding	0		0
Secured credit facility | Line of Credit | Credit Facility Maturing April 2025
Line of Credit Facility [Line Items]
Borrowing capacity under credit facility	$ 100,000,000		$ 100,000,000
Minimum cash requirement								$ 10,000,000
Amendment fee								$ 5,000,000
Amendment fee interest rate (percent)								9.50%
Annualized recurring revenue as ratio of Company's aggregate revenue for preceding quarter	4		4
Discount periods netted from calculation of annualized revenue			1 year
Covenant measurement period on a trailing basis			3 months
Secured credit facility | Term loan | Credit Facility Maturing April 2025
Line of Credit Facility [Line Items]
Minimum interest rate of portion of outstanding principal accruing interest at floating rate (percent)	7%		7%
Interest rate at period end (percent)	9.30%		9.30%
Interest rate of portion of outstanding principal accruing interest at fixed rate (percent)	2.50%		2.50%
Interest capitalized	$ 700,000	$ 700,000	$ 2,100,000	$ 2,100,000
Required closing fee under line of credit	$ 7,000,000		$ 7,000,000
Secured credit facility | LIBOR | Term loan | Credit Facility Maturing April 2025
Line of Credit Facility [Line Items]
Spread on variable rate (percent)			5.50%
Secured credit facility | U.S. prime rate | Term loan | Credit Facility Maturing April 2025
Line of Credit Facility [Line Items]
Spread on variable rate (percent)			2.75%
Class B Common Stock Warrants | Credit Facility Maturing April 2025
Line of Credit Facility [Line Items]
Number of shares that can be purchased (shares)							68,508	100,000	125,000
January 31, 2022 and April 30, 2022 | Secured credit facility | Line of Credit | Credit Facility Maturing April 2025
Line of Credit Facility [Line Items]
Maximum ratio under annualized recurring revenue	0.550		0.550
July 31, 2022 and October 31, 2022 | Secured credit facility | Line of Credit | Credit Facility Maturing April 2025
Line of Credit Facility [Line Items]
Maximum ratio under annualized recurring revenue	0.525		0.525
January 31, 2023 through maturity date | Secured credit facility | Line of Credit | Credit Facility Maturing April 2025
Line of Credit Facility [Line Items]
Maximum ratio under annualized recurring revenue	0.500		0.500

Debt - Schedule of Long-term De

Debt - Schedule of Long-term Debt (Details) - USD ($) $ in Thousands	Oct. 31, 2022	Jan. 31, 2022
Debt Disclosure [Abstract]
Principal	$ 112,705	$ 110,599
Less: unamortized debt issuance costs	(5,281)	(6,611)
Net carrying amount	$ 107,424	$ 103,988

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	Sep. 30, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Letter of credit	$ 3.7

Stockholders' Deficit - Narrati

Stockholders' Deficit - Narrative (Details)	Oct. 31, 2022 vote class $ / shares shares	Jan. 31, 2022 shares	Aug. 31, 2020 $ / shares	Jul. 31, 2020 $ / shares
Class of Stock [Line Items]
Preferred stock authorized (shares)	10,000,000	10,000,000
Preferred stock issued (shares)	0	0
Preferred stock outstanding (shares)	0	0
Number of classes of common stock | class	2
Class B Common Stock Warrants | Minimum
Class of Stock [Line Items]
Exercise price of warrants (in usd per share) | $ / shares			$ 0.01	$ 17.8736
Class B Common Stock Warrants | Maximum
Class of Stock [Line Items]
Exercise price of warrants (in usd per share) | $ / shares	$ 34.35
Class A Common Stock
Class of Stock [Line Items]
Number of votes each share is entitled to | vote	40
Shares to be issued upon conversion (shares)	1
Common stock authorized (shares)	3,263,659	3,263,659
Common stock issued (shares)	3,263,659	3,263,659
Stock outstanding (shares)	3,263,659	3,263,659
Class B Common Stock
Class of Stock [Line Items]
Number of votes each share is entitled to | vote	1
Common stock authorized (shares)	500,000,000	500,000,000
Common stock issued (shares)	31,281,307	29,729,822
Stock outstanding (shares)	31,281,307	29,729,822
Number of shares that can be purchased (shares)	3,333

Equity Incentive Plans - Narrat

Equity Incentive Plans - Narrative (Details) $ / shares in Units, $ in Thousands	1 Months Ended			3 Months Ended			9 Months Ended		11 Months Ended
	Apr. 30, 2022 USD ($) shares	Mar. 31, 2022 USD ($) shares	Jun. 30, 2018 shares	Oct. 31, 2022 USD ($) purchase_period shares	Apr. 30, 2022 $ / shares shares	Oct. 31, 2021 USD ($)	Oct. 31, 2022 USD ($) purchase_period $ / shares shares	Oct. 31, 2021 USD ($)	Apr. 30, 2019 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted in period (shares)				0			0
Options exercised | $				$ 100		$ 7,400	$ 1,500	$ 14,500
Options to purchase common stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period							4 years
Term of award							ten years
Compensation cost not yet recognized | $				34			$ 34
Recognition period for compensation cost not yet recognized							2 months 12 days
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Recognition period for compensation cost not yet recognized							2 years 8 months 12 days
Granted (shares)							2,005,478
Grant date fair value of awards granted (in usd per share) | $ / shares							$ 43.25
Compensation cost not yet recognized | $				$ 179,000			$ 179,000
Vested (in shares)							1,339,137
Accelerated vesting (in shares)	56,000
Accelerated cost | $	$ 2,600
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period					3 years
Granted (shares)					71,667
Threshold trading days					30 days
Threshold consecutive trading days					30 days
PSUs | Tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volume weighted average share price (in usd per share) | $ / shares					$ 60
Grant date fair value of awards granted (in usd per share) | $ / shares					36.07
PSUs | Tranche two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volume weighted average share price (in usd per share) | $ / shares					70
Grant date fair value of awards granted (in usd per share) | $ / shares					33.98
PSUs | Tranche three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volume weighted average share price (in usd per share) | $ / shares					90
Grant date fair value of awards granted (in usd per share) | $ / shares					$ 30.26
Restricted Stock Units, Bonus
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested (in shares)		90,000
Stock-based compensation expense | $		$ 3,600
2018 Equity Incentive Plan (2018 Plan)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Additional shares authorized (shares)							1,649,674		3,500,000
Percentage of outstanding shares (percent)									5%
Common stock reserved for future issuance (shares)				4,033,022			4,033,022
Employee Stock Purchase Plan | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Additional shares authorized (shares)			1,050,000	164,967
Percentage of outstanding shares (percent)			1.50%
Common stock reserved for future issuance (shares)				307			307
Recognition period for compensation cost not yet recognized							8 months 12 days
Compensation cost not yet recognized | $				$ 2,500			$ 2,500
Duration of overlapping offering periods							12 months
Number of purchase periods in each offering period | purchase_period				2			2
Duration of purchase periods							6 months
Share purchase price as percentage of fair value of common stock (percent)				25%			25%
Maximum annual contributions via payroll deductions (shares)							300
Percentage of eligible compensation (percent)							85%
Number of shares available for grant (shares)				368,369			368,369
Assumed increase in shares outstanding (percent)				1.50%			1.50%
Minimum | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period							1 year
Service condition satisfaction period							3 years
Maximum | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period							2 years
Service condition satisfaction period							4 years

Equity Incentive Plans - Recogn

Equity Incentive Plans - Recognized Stock-based Compensation Expense (Details) - 2011 Equity Incentive Plan (the Plan) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 19,207	$ 18,163	$ 64,864	$ 40,851
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	7,336	6,718	23,284	15,192
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	5,909	5,363	19,196	10,603
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	4,807	4,543	18,319	11,596
Interest expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	180	176	550	524
Subscription | Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	667	800	2,176	1,768
Professional services and other | Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 308	$ 563	$ 1,339	$ 1,168

Equity Incentive Plans - Outsta

Equity Incentive Plans - Outstanding Common Stock Options and Related Activity (Details) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2022 USD ($) $ / shares shares	Jan. 31, 2022 USD ($) $ / shares shares
Shares Subject to Outstanding Options
Beginning balance of options outstanding (shares) | shares	963,288
Exercised (shares) | shares	(47,389)
Expired (shares) | shares	(8,990)
Ending balance of options outstanding (shares) | shares	906,909	963,288
Options vested and exercisable, outstanding (shares) | shares	904,304
Weighted- Average Exercise Price per Share
Options outstanding, weighted average exercise price (in usd per share) | $ / shares	$ 26.16
Options exercised, weighted average exercise price (in usd per share) | $ / shares	18.17
Options expired, weighted average exercise price (in usd per share) | $ / shares	37.61
Options outstanding, weighted average exercise price (in usd per share) | $ / shares	26.47	$ 26.16
Options vested and exercisable, weighted average exercise price (in usd per share) | $ / shares	$ 26.45
Additional disclosures
Options outstanding, weighted average remaining contractual term	2 years 1 month 6 days	2 years 10 months 24 days
Options vested and exercisable, weighted average remaining contractual term	2 years 1 month 6 days
Options outstanding, aggregate intrinsic value | $	$ 77	$ 20,166
Options vested and exercisable, aggregate intrinsic value | $	$ 77

Equity Incentive Plans - Outs_2

Equity Incentive Plans - Outstanding RSUs and Related Activity (Details) - Restricted stock units	9 Months Ended
	Oct. 31, 2022 $ / shares shares
Number of Shares
Outstanding as of January 31, 2018 (shares) | shares	4,338,619
Granted (shares) | shares	2,005,478
Vested (in shares) | shares	(1,339,137)
Canceled (shares) | shares	(1,008,921)
Outstanding as of July 31, 2019 (shares) | shares	3,996,039
Weighted- Average Grant Date Fair Value
Outstanding as of January 31,2018 (in usd per share) | $ / shares	$ 55.40
Granted (in usd per share) | $ / shares	43.25
Vested (in usd per share) | $ / shares	51.82
Canceled (in usd per share) | $ / shares	53.35
Outstanding as of July 31, 2019 (in usd per share) | $ / shares	$ 51.01

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Income Tax Disclosure [Abstract]
Income tax expense	$ 167	$ 62	$ 567	$ 89

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2021	Oct. 31, 2022	Oct. 31, 2021
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (23,711)	$ (29,139)	$ (32,888)	$ (28,513)	$ (22,240)	$ (18,104)	$ (85,738)	$ (68,857)
Weighted-average number of shares used in computing net loss per share, basic (shares)	34,392			32,363			33,893	31,758
Weighted-average number of shares used in computing net loss per share, diluted (shares)	34,392			32,363			33,893	31,758
Net loss per share, basic (in usd per share)	$ (0.69)			$ (0.88)			$ (2.53)	$ (2.17)
Net loss per share, diluted (in usd per share)	$ (0.69)			$ (0.88)			$ (2.53)	$ (2.17)
Class A Common Stock
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (2,250)			$ (2,876)			$ (8,257)	$ (7,077)
Weighted-average number of shares used in computing net loss per share, basic (shares)	3,264			3,264			3,264	3,264
Weighted-average number of shares used in computing net loss per share, diluted (shares)	3,264			3,264			3,264	3,264
Net loss per share, basic (in usd per share)	$ (0.69)			$ (0.88)			$ (2.53)	$ (2.17)
Net loss per share, diluted (in usd per share)	$ (0.69)			$ (0.88)			$ (2.53)	$ (2.17)
Class B Common Stock
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (21,461)			$ (25,637)			$ (77,481)	$ (61,780)
Weighted-average number of shares used in computing net loss per share, basic (shares)	31,128			29,099			30,629	28,494
Weighted-average number of shares used in computing net loss per share, diluted (shares)	31,128			29,099			30,629	28,494
Net loss per share, basic (in usd per share)	$ (0.69)			$ (0.88)			$ (2.53)	$ (2.17)
Net loss per share, diluted (in usd per share)	$ (0.69)			$ (0.88)			$ (2.53)	$ (2.17)

Net Loss Per Share - Antidiluti

Net Loss Per Share - Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities that were not included in the diluted net loss per share calculations (shares)	167	3,167	724	3,674
Options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities that were not included in the diluted net loss per share calculations (shares)	6	792	204	812
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities that were not included in the diluted net loss per share calculations (shares)	137	2,240	490	2,369
Employee stock purchase program
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities that were not included in the diluted net loss per share calculations (shares)	24	133	30	433
Common stock warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities that were not included in the diluted net loss per share calculations (shares)	0	2	0	60